Novel Tracers and Radionuclides in PET Imaging.

The use of PET imaging agents in oncology, cardiovascular disease, and neurodegenerative disease shows the power of this technique in evaluating the molecular and biological characteristics of numerous diseases. These agents provide crucial information for designing therapeutic strategies for individual patients. Novel PET tracers are in continual development and many have potential use in clinical and research settings. This article discusses the potential applications of tracers in diagnostics, the biological characteristics of diseases, the ability to provide prognostic indicators, and using this information to guide treatment strategies including monitoring treatment efficacy in real time to improve outcomes and survival.
Competing Interests: Disclosure With regard to the information presented in this article the authors have no potential conflicts of interest to disclose.
(Copyright © 2021 Elsevier Inc. All rights reserved.)